Navigation Links
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Date:7/7/2009

cancer, for which denosumab is administered twice yearly subcutaneously at a 60 mg dose. The Prolia(TM) trade name is only for these indications and may not apply for other indications of denosumab.

(1) Capanna R, Coia LR, Coleman R. et al. eds. Textbook of Bone Metastases. Hoboken, NJ: Edition: John Wiley and Sons; 2005:105.

(2) Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002 Aug;2(8):584-93.

(3) Schulman K and Kohles J. Cancer. 2007;109:2334-2342

(4) GVD/Barber ISPOR 2008 Poster; Schulman 2007; Delea et al. 2006 

    Amgen, Thousand Oaks
    Lisa Rooney, 805-447-6437 (media)
    Arvind Sood, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
4. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
5. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
6. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
7. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
10. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
11. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wire-FirstCall/ -- Watson Pharmaceuticals, Inc. (N...mpany, announced today that Paul Bisaro, Watson,s ...e an overview and update of the Company,s business...rence on Wednesday, November 11, 2009 at 12:00 pm ...l be webcast live and can be accessed on Watson Ph...
(Date:11/6/2009)...re-FirstCall/ -- Roper Industries, Inc. (NYSE: R...ive agreement to acquire Verathon, Inc., a leading...athon Board of Directors has approved the transact...tory approvals and closing conditions, including s...ng to be completed in early December. ,, Headq...
(Date:11/6/2009)...SNewswire/ -- America,s Specialty Medicines Compan...t and smaller innovator pharmaceutical companies, ...ordable Health Care for America Act," introduced b...mpanies fear that the cumulative effect of a host ...ts to bring new medicines to market. ,, From ...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Congress Encouraged to Protect Working Families and Flexible Spending Accounts in New Advertising Campaign 60171 1Congress Encouraged to Protect Working Families and Flexible Spending Accounts in New Advertising Campaign 60171 2CardioGenics Holdings Inc Announces Letter to Shareholders 5757 1CardioGenics Holdings Inc Announces Letter to Shareholders 5757 2CardioGenics Holdings Inc Announces Letter to Shareholders 5757 3Long Island Doctor Shows First 4K Ultra High Definition Surgery 5755 1Long Island Doctor Shows First 4K Ultra High Definition Surgery 5755 2Long Island Doctor Shows First 4K Ultra High Definition Surgery 5755 3
... FOR RELEASE AT 5 P.M. EDT MONDAY, AUG. 4/, /ADVA...r should not be,screened for prostate cancer, and ...of the prostate-specific antigen (PSA) test with t...a new recommendation from the U.S.,Preventive Serv...ng,evidence summary appear in the August 5 issue o...
...nts achieved SVR 12 with 48-week boceprevir-based ... High SVR 24 rate also reported for 28-week bocepr...gh,Corporation (NYSE: SGP ) today reported top-li...ase II study of boceprevir, its investigational,or...owed a high rate of,sustained virologic response (...
Other Medicine Technology:Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 2Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
(Date:11/8/2009)... Health Network (MHN) urges military veterans to l...nked to exposure to chemicals, atomic agents and s... is one of those cancers that is two times more pr...ked or currently smoke cigarettes. , ... -- Men’s Health Network (MHN) kicked-off th...
(Date:11/8/2009)...USNewswire/ -- USAction this evening hailed passag...hich will make health care more affordable for con...ncrease access to health care for millions of Amer...elt, FDR and Harry Truman would be proud," said US...e ranks among our country,s proudest achievements....
(Date:11/8/2009)...es With Working Families vs. Insurance Companies ...re/ -- On the heels of an historic late night vote...ced health care reform bill, the Pennsylvania AFL-...epresentatives voted on HR 3962, the Affordable He... which passed Saturday evening by a vote of 220 to...
(Date:11/7/2009)...Newswire/ -- The American Medical Association (AMA...itizenship and Community Service to Manus C. Kraff...ward recognizes physicians who have gone above and... outstanding public service contribution to their ...y during the opening session of the 2009 Interim M...
(Date:11/7/2009)...USNewswire/ -- With the final House vote on health...ding the entire bill hostage to further their anti...go far beyond the status quo restrictions on abort...ill. In an outrageous amendment, which is expecte...ice Democrats are demanding explicit and unequivoc...
Breaking Medicine News(10 mins):Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
..., researchers say , , MONDAY, March 16 (H... blood flow after a heart attack, but the benefit ..., a new Swiss study finds. , "The main goal of our...iac Rehabilitation Center at the Clinique Valmont-...
...y plays a significant role in the production of al...fter a myocardial infarction, according to a study...ers. , The findings, which will be published on... Beta-arrestin-1 binds to angiotensin II receptors...
...Hilda L. Solis today announced the withdrawal of a...r occupational exposure to food flavorings contain...the Labor Department,s Occupational Safety and Hea...sease associated with such an exposure. , , "I a...
...ly unemployed, can attend a local seminar or talk ...h 16 As the nation marks National Cover the Unins...g resources to help Pennsylvanians without health ...ve risen to one million Pennsylvanians in 2008, up...
...e/Preferred Care and Excellus BlueCross BlueShield...ho treat adults to improve the way patients receiv...health insurers are inviting up to 20 internal med...in or reduce health care costs and to improve phys...
...e the undignified hospital Johnny , , NORTHAMPTON... dedicated to helping homeless veterans of the Uni... integrity, dignity and hope, is looking to restor...l for assisting homeless veterans, hopes to partne...
Other Medicine News:Health News:Any Exercise Good After a Heart Attack 2Health News:Any Exercise Good After a Heart Attack 3Health News:New target for heart failure therapy identified 2Health News:U.S. Secretary of Labor Hilda L. Solis takes action to prevent workers' exposure to food flavorings chemical 2Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 2Health News:Highmark Offers Resources to Help Pennsylvanians Without Health Insurance During Cover the Uninsured Week 3Health News:Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit 2Health News:Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit 3Health News:Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit 4Health News:Non-Profit Seeks Partners for Major Cover-Up 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: